Study on the Requirements and Options for RFID Application in Healthcare

Study on the Requirements and Options for RFID Application in HealthcareThis Report provides an overview of the state of the art in RFID (Radio Frequency Identification) applications in healthcare delivery. It presents the findings of the first phase of a study to identify the policy options that can assist the development and applications of RFID in the delivery of safe and high quality care. The objectives of this first phase - the foundation upon which the rest of the study will be built on - were:
  • first, to identify and discuss the most relevant areas for deployment and use of RFID in healthcare
  • second, to shed light on the most important enablers, obstacles and uncertainties that have the potential to influence RFID use in healthcare applications
  • finally, to include a discussion of other alternatives to RFID technologies.

A thorough, systematic review of all relevant literature was conducted to generate a comprehensive overview of the existing information. Peer-review literature and 'grey' literature, including various organisations' reports, presentation material and commercial publications, were identified and searched. An electronic database was created to record the findings. Data were abstracted and recorded in a specially created summary template, then summarised and analysed. We categorised the findings according to RFIDenabling function (tracking, identification and authentication, automatic data collection and transfer, and sensing) and subject (staff, patients, assets and clinical trials). The database included 325 items.

Download Study on the Requirements and Options for RFID Application in Healthcare Report (.pdf, 636 KB).

Download from the eHealthNews.EU Portal's mirror: Study on the Requirements and Options for RFID Application in Healthcare Report (.pdf, 636 KB).

For further information please contact:
Constantijn van Oranje
RAND Europe
37 Square de Meeus
B-1000 Brussels
www.randeurope.org

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

AI in Drug Discovery Conference 2020

16 - 17 March 2020, London, UK. SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London. AI-empowered machine learning technologies hold the potential...